Effect of obstructive jaundice on neutrophil chemotactic activity: An in vivo assessment in zymosan-induced peritonitis model in rats

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 4, 1998, Pages 405-411

  Yamamoto, Shin ^a   Kubota, Yoshitsugu ^a   Tsuji, Kazuyuki ^a   Yanagitani, Kaori ^a   Takaoka, Makoto ^a   Kin, Hideyuki ^a   Ogura, Mami ^a   Inoue, Kyoichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemotaxis; Jaundice; Neutrophils; Peritonitis

Indexed keywords

MYELOPEROXIDASE; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; ENZYME ACTIVITY; HOST RESISTANCE; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OBSTRUCTIVE JAUNDICE; PERITONITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0031965529     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00655.x     Document Type: Article

References (19)

1. Holman JM, Rikkers LF, Moody FG. Sepsis in management of complicated biliary disorders. Am. J. Surg. 1979; 138: 809-13.
2. Armstrong CP, Dixon JM, Taylor TV, Davies GC. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br. J. Surg. 1984; 71: 234-8.
3. Levy R, Schlaeffer F, Keynan A, Nagauker O, Yaari A, Skuler E. Increased neutrophil function induced by bile duct ligation in a rat model. Hepatology 1993; 17: 908-14.
4. Andy OJ, Grogan JB, Griswold JA, Scott-Conner CEH. Peritoneal neutrophil chemotaxis is impaired in biliary obstruction. Am. Surg. 1992; 58: 28-31.
5. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 1993; 11: 767-804.
6. Downey GP. Mechanisms of leukocyte motility and chemotaxis. Curr. Opin. Immunol. 1994; 6: 113-24.
7. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-4.
8. Obayashi T, Tamura H, Tanaka S et al. A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin. Chim. Acta. 1985; 149: 55-65.
9. Levy R, Malech HL, Rotrosen D. Production of myeloid cell cytosols functionally and immunochemically deficient in the 47 KDa or 67 KDa NADPH oxidase cytosolic factors. Biochem. Biophys. Res. Commun. 1990; 170: 1114-20.
10. Ward PA, Chochrane CG, Müller-Eberhard HJ. The role of serum complement in chemotaxis of leukocytes in vitro. J. Exp. Med. 1965; 122: 327-47.
11. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal. Biochem. 1983; 132: 345-52.
12. Van der Vliet A, Van der Poel KI, Bast A. Intestinal smooth muscle dysfunction after intraperitoneal injection of zymosan in rat: are oxygen radicals involved? Gut 1992; 33: 336-41.
13. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 1982; 78: 206-9.
14. Damas J, Bourdon V, Remacle-Volon G, Adam A. Kinins and peritoneal exudates induced by carrageenin and zymosan in rats. Br. J. Pharmacol. 1990; 101: 418-22.
15. Barja-Fidalgo C, Carlini CR, Guimaràes JA, Flores CA, Cunha FQ, Ferreira SH. Role of resident macrophages in canatoxin-induced in vivo neutrophil migration. Inflammation 1992; 16: 1-12.
16. Souza GEP, Cunha FQ, Mello R, Ferreira SH. Neutrophil migration induced by inflammatory stimuli is reduced by macrophage depletion. Agents Actions 1988; 24: 377-80.
17. Obayashi T, Tamura H, Tanaka S, Ohki M, Takahashi S, Kawai T. Endotoxin-inactivating activity in normal and pathological human blood samples. Infect. Immun. 1986; 53: 294-7.
18. Bode C, Fukui H, Bode JC. 'Hidden' endotoxin in plasma of patients with alcoholic liver disease. Eur. J. Gastroenterol. Hepatol. 1993; 5: 257-62.
19. Greve JW, Gouma DJ, Soeters PB, Buurman WA. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats. Gastroenterology 1990; 98: 478-85.